The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 3
Abstract
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Materials and Methods: Between July 2016 and September 2018, a total of 25 CHD patients treated with PrOD were enrolled. The patients with hepatitis C virus (HCV) genotype 1a were treated with PrOD plus ribavirin (RBV) (12 or 24 weeks according to whether or not they had compensated cirrhosis), while the patients with genotype 1b were treated with PrOD alone. Liver functions, renal functions, and HCV-RNA levels were measured at baseline, 4, 12, and if applicable, 24 weeks after the initiation of treatment as well as 4 and 12 weeks after therapy. Results: Nineteen patients received PrOD, while 6 received PrOD plus RBV treatment. Two patients failed to complete the treatment. Two patients with compensated cirrhosis were treated over 24 weeks, while others received 12 weeks. In 23 patients completed 12 weeks, all were HCV-RNA negative at the end of the treatment, and had sustained virologic response (SVR) after the 12 weeks of treatment. The most common side effects were pruritus and anaemia. Conclusion: The PrOD treatment resulted in a high rate of SVR in HCV-infected CHD.
Authors and Affiliations
Nilay Danış, Hüsnü Pullukçu, Tansu Yamazhan, Galip Ersöz, Nalan Ünal, Fulya Günşar, İlker Turan, Zeki Karasu, Ulus Salih Akarca
Keywords
Related Articles
- EP ID EP676549
- DOI 10.4274/vhd.galenos.2019.2019.0028
- Views 126
- Downloads 0
Which is More Important and Insidious in Dialysis Patients? Occult Hepatitis B or Occult Hepatitis C?
Objectives: The aim of this study was to investigate the presence of occult hepatitis B infection (OBI) and Occult hepatitis C infection (OCI) in hemodialysis patients and to determine whether there is an activation in t...
The Evaluation of the Relation Between Drug Compliance and Psychometric Tests in Chronic B Hepatitis Patients Who are Treated with Oral Antivirals
Objectives: Hepatitis B is a viral infection that causes acute and chronic hepatitis and serious complications such as cirrhosis and hepatocellular cancer. Several psychiatric symptoms and depression, particularly anxiet...
An Evaluation of Health Personnel Exposed to Occupational Injuries in Terms of HBV, HCV, and HIV Infections
Objectives: This study aims to determine the rates, distribution and risk factors of needle-stick and sharps injuries that cause diseases spread through blood and body fluids, to discuss relevant precautions, and to moni...
An Evaluation of Hepatitis B Virus and Hepatitis C Virus Frequency and the Anti-hepatitis B Surface Seropositivity of Syrian Refugees in the Karabük Province
Objectives: To investigate the frequency of hepatitis B Virus (HBV) and HCV with anti- hepatitis B Surface (HBs) seropositivity using serological and molecular methods in Syrian refugees in the Karabük. Materials and Me...
microRNA in Patients with Hepatitis B and Hepatitis C Virus Associated Hepatocellular Carcinoma and Cirrhosis
Objectives: The aim of this study was to determine the potentials of hsa-microRNAs (miRNA)-21-3p, hsa-miRNA-29a-3p, hsa-miRNA-122-3p, hsa-miRNA-192-5p in Hepatitis B (HBV) and HCV related hepatocellular carcinoma (HCC) a...